PMV Pharmaceuticals Inc. Common Stock (PMVP)
Stock · NASDAQ · Health Care
$1.22as of 8/28/2026
Price chart
Open in TradingViewActive signals
200 SMA Touch56.9%
High Beta22.2%
Support level
$1.06
Industry
Biotechnology: Pharmaceutical Preparations
About PMVP
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 54
- Website
- www.pmvpharma.com/
Fundamentals
- 1-day range
- $1.22$1.25
- Market cap
- $62.93M
- P/E (trailing)
- —
- P/E (forward)
- -1.07
- EPS (trailing)
- $-1.48
- Dividend yield
- —
- Beta
- 1.41
- Avg. volume
- 301.2K
52-week range
$1.02$1.88
Next earnings: November 16, 2026 · EPS estimate $-0.38confirmed
Forecasts
4 analyst ratings
Buy 92%
Hold 8%
Sell 0%
1-year price forecast
High
$5
+309.8%
Median
$4
+227.9%
Low
$3
+145.9%
PMV Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PMVPPMV Pharmaceuticals Inc. Common Stock$1.22▼ 1.61%Market cap $62.93MP/E —$1.02$1.88
- BOLDBoundless Bio Inc. Common Stock$2.83▼ 1.05%Market cap $63.80MP/E —$0.9612$3.16
- XLOXilio Therapeutics Inc. Common Stock$9▼ 0.22%Market cap $60.95MP/E —$6.47$12.74
- PLRXPliant Therapeutics Inc. Common Stock$1.11▼ 3.48%Market cap $65.02MP/E —$1.02$1.95
- MNOVMedicinova Inc Common Stock$1.44▲ 1.05%Market cap $66.94MP/E —$1.17$1.96
- DWTXDogwood Therapeutics Inc. Common Stock$2.6▲ 12.07%Market cap $58.85MP/E 1.84$1.28$9.5
- RNTXRein Therapeutics Inc. Common Stock$0.7621▼ 2.67%Market cap $67.45MP/E —$0.694$2.18
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PMVP PMV Pharmaceuticals Inc. Common Stock | $62.93M | — | $1.22 | ▼ 1.61% | $1.02$1.88 |
| BOLD Boundless Bio Inc. Common Stock | $63.80M | — | $2.83 | ▼ 1.05% | $0.9612$3.16 |
| XLO Xilio Therapeutics Inc. Common Stock | $60.95M | — | $9 | ▼ 0.22% | $6.47$12.74 |
| PLRX Pliant Therapeutics Inc. Common Stock | $65.02M | — | $1.11 | ▼ 3.48% | $1.02$1.95 |
| MNOV Medicinova Inc Common Stock | $66.94M | — | $1.44 | ▲ 1.05% | $1.17$1.96 |
| DWTX Dogwood Therapeutics Inc. Common Stock | $58.85M | 1.84 | $2.6 | ▲ 12.07% | $1.28$9.5 |
| RNTX Rein Therapeutics Inc. Common Stock | $67.45M | — | $0.7621 | ▼ 2.67% | $0.694$2.18 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- PMV Pharma Q2 EPS $(0.34) Beats $(0.39) Estimatebenzinga · 8/14/2026
- PMV Pharma Q2 EPS $(0.34) Beats $(0.39) EstimateBenzinga · 8/14/2026
Insider Activity
Insider Actions →Acquired
1.82M
Disposed
42.0K
- FLOWERS KIRSTEN · June 4, 2026 · Grant42.0K
- Stelzer Laurie · June 4, 2026 · Grant42.0K
- Charles M. Baum · June 4, 2026 · Grant42.0K
- Carol Giltner Gallagher · June 4, 2026 · Gift42.0K
- Carol Giltner Gallagher · June 4, 2026 · Grant42.0K
- LEVINE ARNOLD J · June 4, 2026 · Grant42.0K
- Michael Carulli · March 5, 2026 · Grant240.0K
- Deepika Jalota · March 5, 2026 · Grant303.3K
- Robert Ticktin · March 5, 2026 · Grant319.3K
- David Henry Mack · March 5, 2026 · Grant745.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 36.73M
- Total value held
- $42.71M
- Institutional holders
- 66
Top holders this quarter
- Unknown5.32M
- Unknown4.25M
- Unknown3.08M
- Unknown2.87M
- Unknown2.63M
- Unknown2.35M
- Unknown2.22M
- Unknown1.97M
- Unknown1.88M
- Unknown1.86M
See the full, filterable feed with live charts on the MarketWall dashboard.